Award of contract for SIMOA Immunoassay Equipment

Award of contract without seeking offers through a formal procurement procedure due to the fact that competition is absent for technical reasons.

We can currently detect approximately tau down to about 30 pg/mL, whereas the levels of protein expected in plasma are in the region of 10-20 pg/mL. SIMOA has the ability to measure single molecules in a novel technology that is proprietary for Quanterix and supplied exclusively by Quanterix.

Under clause 6(1) (b) (ii) of the legislation, a contracting authority may award a contract without competition (only where no reasonable alternative or substitute exists and the absence of competition is not the result of artificial narrowing down of parameters of the procurement). In this case, the grounds for not exposing to competition are as follows:

• The digital immunoassay instrument provided by the supplier is the only one available in the market that has the ability to measure single molecules to the level required.
• Quanterix holds the patent for the SIMOA technology platform

Lots

This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.

Tender Documents

• Award of contract for SIMOA Immunoassay Equipment → — Award notice